Greenstone Llc
Greenstone Llc appears in FDA public data with 7 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0299-2026, Class II) was initiated on January 15, 2026.
Summary
- Total Recalls
- 7 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0299-2026 | Class II | methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx o | January 15, 2026 |
| D-1361-2014 | Class I | Venlafaxine HCl Extended-Release Capsules, 150 mg, 90-count Unit of Use bottles, Rx only, Distribute | March 6, 2014 |
| D-746-2014 | Class II | sertraline HCl tablets, 25 mg, 30 Tablets, Rx only, GREENSTONE BRAND --- Distributed by: Greenstone | November 5, 2013 |
| D-1059-2014 | Class III | Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by | November 4, 2013 |
| D-737-2014 | Class II | Nifedipine, extended-release tablets, 90mg 100 count blister pack, Rx only, Distributed by: GREENST | November 1, 2013 |
| D-010-2014 | Class II | Spironolactone tablets, USP 25 mg, Rx only, 500 count bottle, Distributed By: Greenstone LLC, Peapac | September 4, 2013 |
| D-011-2014 | Class II | Spironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapac | September 4, 2013 |